EP4072469A1 - Intraokularlinse und verfahren zum ersetzen einer natürlichen augenlinse - Google Patents
Intraokularlinse und verfahren zum ersetzen einer natürlichen augenlinseInfo
- Publication number
- EP4072469A1 EP4072469A1 EP20829810.9A EP20829810A EP4072469A1 EP 4072469 A1 EP4072469 A1 EP 4072469A1 EP 20829810 A EP20829810 A EP 20829810A EP 4072469 A1 EP4072469 A1 EP 4072469A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- membrane
- intraocular lens
- capsular bag
- lens
- eye
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims description 16
- 239000012528 membrane Substances 0.000 claims abstract description 111
- 238000003780 insertion Methods 0.000 claims abstract description 7
- 230000037431 insertion Effects 0.000 claims abstract description 7
- 239000012780 transparent material Substances 0.000 claims abstract description 6
- 230000004308 accommodation Effects 0.000 claims description 23
- 230000003595 spectral effect Effects 0.000 claims description 12
- 230000000694 effects Effects 0.000 claims description 11
- 239000000463 material Substances 0.000 claims description 10
- 230000001419 dependent effect Effects 0.000 claims description 4
- 230000006835 compression Effects 0.000 claims description 3
- 238000007906 compression Methods 0.000 claims description 3
- 229920001296 polysiloxane Polymers 0.000 claims description 3
- 230000002146 bilateral effect Effects 0.000 claims description 2
- 229920001971 elastomer Polymers 0.000 claims description 2
- 239000000806 elastomer Substances 0.000 claims description 2
- 239000004816 latex Substances 0.000 claims description 2
- 229920000126 latex Polymers 0.000 claims description 2
- 150000002825 nitriles Chemical class 0.000 claims description 2
- 238000006073 displacement reaction Methods 0.000 claims 2
- 230000003287 optical effect Effects 0.000 description 12
- 230000008859 change Effects 0.000 description 8
- 210000003205 muscle Anatomy 0.000 description 8
- 230000008901 benefit Effects 0.000 description 7
- 230000000875 corresponding effect Effects 0.000 description 6
- 238000001356 surgical procedure Methods 0.000 description 6
- 208000002177 Cataract Diseases 0.000 description 5
- 238000012937 correction Methods 0.000 description 5
- 238000000862 absorption spectrum Methods 0.000 description 4
- 230000002745 absorbent Effects 0.000 description 3
- 239000002250 absorbent Substances 0.000 description 3
- 238000004873 anchoring Methods 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 230000000007 visual effect Effects 0.000 description 3
- 230000002350 accommodative effect Effects 0.000 description 2
- 201000009310 astigmatism Diseases 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 230000001886 ciliary effect Effects 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000004049 embossing Methods 0.000 description 2
- 238000002513 implantation Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 238000004026 adhesive bonding Methods 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 210000002159 anterior chamber Anatomy 0.000 description 1
- 210000001742 aqueous humor Anatomy 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000004240 ciliary body Anatomy 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 210000004087 cornea Anatomy 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000036040 emmetropia Effects 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000002114 nanocomposite Substances 0.000 description 1
- 239000002105 nanoparticle Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 201000010041 presbyopia Diseases 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 238000002834 transmittance Methods 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/14—Eye parts, e.g. lenses or corneal implants; Artificial eyes
- A61F2/16—Intraocular lenses
- A61F2/1613—Intraocular lenses having special lens configurations, e.g. multipart lenses; having particular optical properties, e.g. pseudo-accommodative lenses, lenses having aberration corrections, diffractive lenses, lenses for variably absorbing electromagnetic radiation, lenses having variable focus
- A61F2/1624—Intraocular lenses having special lens configurations, e.g. multipart lenses; having particular optical properties, e.g. pseudo-accommodative lenses, lenses having aberration corrections, diffractive lenses, lenses for variably absorbing electromagnetic radiation, lenses having variable focus having adjustable focus; power activated variable focus means, e.g. mechanically or electrically by the ciliary muscle or from the outside
- A61F2/1635—Intraocular lenses having special lens configurations, e.g. multipart lenses; having particular optical properties, e.g. pseudo-accommodative lenses, lenses having aberration corrections, diffractive lenses, lenses for variably absorbing electromagnetic radiation, lenses having variable focus having adjustable focus; power activated variable focus means, e.g. mechanically or electrically by the ciliary muscle or from the outside for changing shape
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/14—Eye parts, e.g. lenses or corneal implants; Artificial eyes
- A61F2/16—Intraocular lenses
- A61F2/1613—Intraocular lenses having special lens configurations, e.g. multipart lenses; having particular optical properties, e.g. pseudo-accommodative lenses, lenses having aberration corrections, diffractive lenses, lenses for variably absorbing electromagnetic radiation, lenses having variable focus
- A61F2/1654—Diffractive lenses
- A61F2/1656—Fresnel lenses, prisms or plates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/14—Eye parts, e.g. lenses or corneal implants; Artificial eyes
- A61F2/16—Intraocular lenses
- A61F2/1602—Corrective lenses for use in addition to the natural lenses of the eyes or for pseudo-phakic eyes
- A61F2/161—Posterior chamber lenses for use in addition to the natural lenses of the eyes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/14—Eye parts, e.g. lenses or corneal implants; Artificial eyes
- A61F2/16—Intraocular lenses
- A61F2/1613—Intraocular lenses having special lens configurations, e.g. multipart lenses; having particular optical properties, e.g. pseudo-accommodative lenses, lenses having aberration corrections, diffractive lenses, lenses for variably absorbing electromagnetic radiation, lenses having variable focus
- A61F2/1648—Multipart lenses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/14—Eye parts, e.g. lenses or corneal implants; Artificial eyes
- A61F2/16—Intraocular lenses
- A61F2002/1681—Intraocular lenses having supporting structure for lens, e.g. haptics
- A61F2002/1689—Intraocular lenses having supporting structure for lens, e.g. haptics having plate-haptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2210/00—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2210/0014—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof using shape memory or superelastic materials, e.g. nitinol
- A61F2210/0019—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof using shape memory or superelastic materials, e.g. nitinol operated at only one temperature whilst inside or touching the human body, e.g. constrained in a non-operative shape during surgery, another temperature only occurring before the operation
Definitions
- the invention relates to an intraocular lens which has a lens body and is designed for insertion into the human eye, as well as a method for replacing a natural eye lens.
- Intraocular lens (IOL) insertion is a common treatment for treating cataracts.
- the lens of the eye clouded by the cataract is removed and replaced with an implanted intraocular lens.
- the insertion of an intraocular lens may also be necessary for other reasons.
- optical concepts have been implemented that realize the correction of presbyopia and / or correct an astigmatism.
- cataract surgery experienced a change from classic geriatric surgery to refractive surgery with the aim of achieving freedom from glasses over all visual distances and with the highest quality of vision.
- the great majority of the intraocular lenses are implanted in the remaining empty remainder of the capsular bag.
- anterior capsular bag membrane is opened by a capsulorhexis, the natural lens of the eye is crushed and removed, and the posterior chamber intraocular lens is inserted into the remaining capsular bag.
- Posterior chamber intraocular lenses have holding devices that are referred to as “haptics” and are attached to the optically effective lens body of the intraocular lens in order to fix and position it correctly in the capsular bag.
- Another way to use an intraocular lens is to fix it to the iris. So-called anterior chamber intraocular lenses are used for this purpose.
- WO 00/21467 A1 US 2013/190868 A, US 6007579 A, US 2003/158560 A, US 2002/143394 A, US 2007/244561 A, US 2010/204787 A, WO 2012/054854 A2, EP 1667612 A1, US 5443506 A, US 5066301, AU 2004/02852, WO 2008/077795 A2, US 9095424 B2, WO 2017/096087 A1 and CA 3002085 A1.
- the invention is based on the object of specifying an improved intraocular lens and an improved method for cataract surgery.
- the intraocular lens has a lens body and is designed for insertion into the human eye.
- the lens body is designed as a flat, elastically stretchable, preferably planparal lele membrane made of transparent material.
- a planar focusing system is formed on or in this membrane. Due to the elastic stretchability of the transparent material, the focusing system formed in or on the diaphragm is also stretched when the diaphragm is stretched, with the stretching changing the focusing system in such a way that the focal length changes.
- Examples of a planar focusing system are Fresnel zone structures that can be phase and / or amplitude modulated. Diffractive structures are also possible.
- the intraocular lens is placed in the eye in such a way that the muscles of the eye stretch or relax the elastic-stretchable membrane while accommodating, preferably radially symmetrically.
- the membrane is elastically stretched in such a way that a change in the focal length of the intraocular lens and thus the desired adaptation that is required for visual accommodation results.
- the membrane of the implanted IOL is stretched elastically by the muscles that are naturally activated during the process of accommodation.
- planar focusing systems are planar lenses made of metamaterials, hologram-generating surfaces and / or phase- and / or amplitude-modulated systems.
- Metamaterials are systems, such as nano- or microstructures, which allow an unusual refractive power, for example less than 1 or negative values.
- microresonators or plasmonic systems with dimensions in the range of hundreds of nanometers to a few micrometers. The size depends on the wavelength of the interacting light. Depending on the resonator system, the decisive structure size is usually in the range from 0.1 to 2x the wavelength.
- the systems are indeed three-dimensional from a microscopic point of view, but can still be viewed as planar in comparison to the thickness of the membrane.
- a lens can be produced which, viewed macroscopically, also realizes a planar focusing system.
- the membrane can be fastened within the capsular bag and / or over a capsulorhexis opening.
- at least one haptic is optionally provided for securely attaching the membrane to the capsular bag of the eye.
- the membrane can be provided with through openings at the edge, which allow the membrane to be sewn to the capsular bag over the capsulorhexis.
- the membrane can be introduced into the capsular bag and attached to its inner wall.
- the haptics are particularly preferably arranged on the edge of the membrane, with several haptics being arranged in a ring on the edge of the membrane.
- Such haptics can particularly preferably be attached to the inner circumference of a ring, which in turn is designed to be attached to the capsular bag equator of the eye.
- the ring which can be segmented particularly preferably, is attached to the capsular bag equator, for example glued.
- the membrane is attached to the inside of the ring, for example glued or fastened by snap-in connections, etc.
- the size of the intraocular lens is exclusively defined by the geometry of the membrane.
- the comparatively thin membrane can be rolled up tightly and can thus achieve a very small cross-section for the implantation process.
- the cut sizes in cataract surgery are thus reduced compared to the prior art, which leads to improved wound healing and an improved overall surgical result.
- the cutting size is independent of the refractive power of the intraocular lens, which is not the case with conventional intraocular lenses.
- the planar focusing system has a Fresnel zone structure, which is preferably characterized by a sequence of concentric, light-absorbing rings which are each separated from one another by transparent rings. So rings that block the light are followed by rings that transmit the light.
- a Fresnel zone structure can particularly preferably be achieved by coloring a transparent, elastically stretchable material in membrane form, for example by means of corresponding particles, dyes, etc., which are printed on the membrane or introduced into the membrane.
- l stands for the wavelength
- r n for the nth transition between a transparent and an absorbing ring area
- D for the refractive power in diopters.
- the factor s is linked to the enlargement of the Fresnel zone structure, which is generated by the stretching of the membrane.
- the basic geometry of the (unstretched) Fresnel zone structure is given by the radius r n , which defines the basic focal length fo of the unstretched structure.
- the planar focusing system has a phase modulating Fresnel zone structure, which is preferably characterized by a sequence of annular thickenings of the plate.
- a phase modulating Fresnel zone structure which is preferably characterized by a sequence of annular thickenings of the plate.
- A stands for the area of the stretched membrane and Ao for the area of the unstretched membrane.
- Such diffractive structures have the same effect in terms of expansion as an amplitude-modulated Fresnel zone structure with absorbing rings and non-absorbing ring gaps. They are made, for example, by embossing an elastic membrane and have a non-even surface. Their transmittance can be higher.
- Diffractive systems are, for example, phase or amplitude modulated systems. They generate interference by blocking or amplitude shifting and use this to generate a focus.
- nanoparticle systems for example known from D. Werdehausen et al., “Dispersion-engineered nanocomposites enable achromatic diffractive optical elements”, Optica, 2019, can be used to increase efficiency, as they direct more light into the first diffraction order.
- the elastic properties of the membrane are preferably matched to the physiology of the eye by using a very flexible material for the membrane.
- a modulus of elasticity between 0.5 MPa and 1.5 MPa, preferably 1 MPa ⁇ 10%
- the force that can be achieved by the eye muscles in the ciliary body allows a membrane thickness of 30 gm to 50 gm, preferably 35 gm ⁇ 20%, and a diameter of the membrane (measured without any haptics) of 4 mm, a change in the refractive index from about 20 diopters to 26 diopters. This corresponds to a focus adjustment from 40 cm to 4 m for a standard eye.
- Suitable materials for producing the elastic-stretchable membrane are elastomers made of silicone, nitrile and / or latex.
- the described intraocular lens is generally dependent on the wavelength with regard to the focal length, as, for example, the above equation (1) shows.
- This problem arises when used as an intraocular lens to a lesser extent than in conventional optical applications, since the human brain is able to correct such errors.
- the task arises, one Lens that has a planar focusing system, for example as a Fresnel zone structure, in a flexible membrane to be designed so that the optical quality is improved. This task also arises regardless of whether it is used as an intraocular lens.
- a lens which has a lens body which is designed as a flat (preferably plane-parallel), elastically stretchable and / or elastically deformable membrane made of transparent material, on or in the planar focusing system as an amplitude-modulated Fresnel zone structure, with the Fresnel zone structure has at least two zones which differ in terms of their spectral selectivity and their geometry, where each zone acts in a spectral range in which the at least one other zone does not act.
- the zones are sets of concentric, spectrally selective light-absorbing ring zones of the Fresnel zone structure which absorb spectrally differently in order to provide the spectrally selective effect.
- This Fresnel zone structure therefore has several ring zone structures, each of which is optimized for a specific wavelength or a specific wavelength range. The wavelength range is given by the range in which the respective ring zone structure absorbs. The ring zone structure is matched to the respective wavelength range in which the corresponding ring zone structure is subordinate.
- the individual geometries of the zones are selected in such a way that the respective wavelength in which the corresponding zones act is obtained the same focal length as for the other zones. In this way a chromatic correction is achieved.
- the individual zones therefore do not interact with one another in terms of focus generation, since each zone only acts in an individual wavelength range.
- the Fresnel zone structure consists of a superposition of at least two ring zone structures which absorb in an individual wavelength range in which the other ring zone structures or the other ring zone structure is transparent.
- These ring zone structures have ring geometries that are matched to the respective wavelength range. All ring zone structures are designed in such a way that they produce the same focal length in the wavelength range assigned to them. Since the other ring zone structures do not absorb in the wavelength range of a ring zone structure, a chromatic correction can be achieved very easily in this way.
- the individual ring zone structures do not interact with one another in terms of focus generation, since each ring zone structure only acts in an individual wavelength range. In this way, for example, an adjustment for blue, green and red can be generated with three ring zone structures.
- This principle can of course be used particularly preferably for the intraocular lens mentioned at the beginning. However, it is also generally intended for optical systems (e.g. lenses) whose focal length is to be adjusted.
- the membrane does not necessarily have to be subjected to an expansion lying in one plane, as is the case with the intraocular lens. Rather, a deformation is equally possible, as described in the article by X. Li et al. is described.
- the expansion of the membrane is brought about by the natural accommodation activity.
- the intraocular lens is suitably connected to the capsular bag. In embodiments, this can be done in such a way that the increase in the maximum capsular bag diameter also causes the intraocular lens to expand.
- the intraocular lens is attached in or near the capsular bag equator. In otheryaksfor men, the expansion takes place indirectly, in that the axial compression of the capsular bag associated with the expansion of the capsular bag is converted into the expansion of the membrane via a mechanism. This construction has the advantage that no force-fit fastening on or near the capsular bag equator is required.
- the intraocular lens can have a non-accommodating additional lens. This is particularly advantageous when the intraocular lens has to provide a comparatively high refractive power that could not be realized by the flexible membrane alone or only with optical restrictions.
- the additional lens can also bring advantages in other cases, since the refractive power of the planar focusing system can be reduced.
- the intraocular lens then additionally comprises an additional lens, which is usually curved, which is arranged, for example, posterior or anterior to the elastic membrane and which is not influenced by the accommodation activity of the eye. It provides a basic refractive power that is desirable for medical and / or optional reasons, for example. It goes without saying that the features mentioned above and those yet to be explained below can be used not only in the specified combinations, but also in other combinations or on their own without departing from the scope of the present invention.
- Fig. 1 is a schematic representation of an eye with inserted, elastic intraocular lens
- Fig. 2 is a schematic representation to illustrate the accommodation with the intraocular lens of Fig. 1
- Fig. 3 is a plan view and a sectional view of an elastic part of the intraocular lens of Figs. 1 and 2, which is designed as an amplitude-modulated Fresnel zone plate,
- Fig. 4 is a schematic illustration to explain the implantation and anchoring of the intraocular lens in the eye
- Fig. 5 is a plan view similar to Fig. 3, the haptics of the intraocular lens shows additional Lich,
- FIG. 6 shows a representation similar to FIG. 4 relating to a different type of anchoring of the intraocular lens
- FIG. 7 shows an enlarged detail of FIG. 6 to explain the anchoring of the intraocular lens
- FIG. 8 and 9 are schematic representations similar to FIG. 3 relating to a chromatically corrected lens
- FIG. 13 shows a representation similar to FIG. 4, the Fresnel zone plate being formed in a curved membrane
- an additional lens is provided in addition to the elastically stretchable intraocular lens in order to increase the optical effect of the intraocular lens
- FIG. 16 shows an embodiment similar to that of FIG. 14, a different mechanical principle being used to convert the deformation of the capsular bag which occurs during accommodation into a stretching of an elastic part of the intraocular lens.
- FIG. 1 schematically shows a sectional illustration through an eye 2 which has a cornea 4.
- the intraocular lens 6 is fastened in a capsular bag 8, from which the natural lens of the eye has been removed through an opening which is not shown in detail.
- the capsular bag 8 is stretched by a cillary muscle 10 via cillary fibers 12 for accommodation.
- the fastening of the intraocular lens 6 in the capsular bag 8 is such that the intraocular lens 6 follows this expansion, that is to say is stretched when the cillary muscles 10 are shortened. The corresponding effect can be seen in FIG.
- the expansion of the intraocular lens 6 changes the focus length between a near focus fN and a far focus fF.
- the intraocular lens 6 is stretched in that it follows the enlargement of the capsular bag that occurs during accommodation.
- it is suitably fastened, for example, to the capsular bag equator or connected to the sem with tensile strength.
- the implementation of the activity of the ciliary muscles 10 in an expansion of the intraocular lens 6 can, however, as will be explained below, also take place in other ways. Insofar as the focus below is on fastening the intraocular lens in the area of the capsular bag equator, this is only to be understood as an example.
- the intraocular lens 6 comprises an amplitude-modulated Fresnel zone structure 13 which is formed on a transparent membrane 14.
- a ring structure 15 made of radiation-absorbing rings 16 is formed on this transparent membrane 14.
- the amplitude modulation is not mandatory.
- phase modulation can alternatively be used, as will be explained below with reference to FIGS. 11 and 12. It is essential that the intraocular lens has an elastic membrane 14 and on / in this has a planar focusing system, the focal length of which depends on the expansion of the elastic membrane 14 depends. As a result, an expansion of the membrane 14 is converted into a change in the refractive power and therewith the optical effect of the intraocular lens 6, so that the natural accommodation capacity is maintained or becomes possible again.
- An expansion of the amplitude-modulated Fresnel zone structure 13 formed in the membrane 14 changes the geometry of the ring structure 15 (e.g. the distances between the rings 16) and thus the focal length. The same applies in the case of the phase-modulated Fresnel zone structure and / or in the case of diffractive structures. In this way, an expansion of the membrane 14, which consists of an elastically stretchable material, can be implemented for accommodation.
- the intraocular lens 6 is fastened in the eye in such a way that the natural accommodation activity causes a corresponding expansion of the membrane 14 of the intraocular lens 6. It has been found to be particularly preferred that the modulus of elasticity of the membrane 14 is approximately 1 MPa ⁇ 30%. Furthermore, the Poisson's number is preferably slightly below 0.5, particularly preferably 0.49. The value ranges mentioned above in the general part of the description have been found to be useful for generating the desired change in focal length during accommodation.
- the thickness h of the transparent membrane 14 is, for example, 35 ⁇ m, its diameter d 4 mm. Since the central area of the Fresnel zone structure 13 has no optical effect, an optional hole 18 is formed here. This allows the aqueous humor to flow between sections posterior and sections anterior of the intraocular lens 6. The Fresnel zone structure 13 generates a focus and is measured in such a way that the optical effect of the removed natural lens of the eye is replaced.
- the intraocular lens 6 is provided on the edge of the flexible len membrane 14 with haptics 20, which can either be formed from the same material as the flexible membrane 14, or are more rigid. PMMA, silicone, IOL material such as hydrophobic or hydrophilic acrylate can be used as rigid material.
- the haptics 20 are attached on the one hand to the edge of the membrane 14 and, on the other hand, to a ring 22 which, in turn, is firmly attached in the capsular bag equator.
- the advantage of such a configuration with a stiffer edge is that the expansion is limited to a central area of the membrane 14, whereby a greater change in position of the focus position is possible.
- the ring 22 can, as the plan view of FIG. 5 shows, be segmented. It then has ring segments 24 in which the ring 22 is enlarged and designed for attaching the flaptics 20.
- the flaptics 20 are preferably designed as fixed webs, so that there is an opening between the individual haptics 20, which is used for fluid exchange. At the same time, the webs ensure the necessary transfer of force between the capsular bag 8 and the elastic-stretchable membrane 14.
- the haptics 20 can also have openings 24 for their part. It is equally possible to design the haptics 20 as a single ring-shaped haptic.
- the stretching to fasten the elastic-stretchable membrane 14 with the Fresnel zone structure 13 in the eye 2 in such a way that it is stretched radially symmetrically.
- the haptics 20 are therefore arranged in a ring with an angular spacing of 45 °.
- the number of haptics can also be reduced or decreased. In simplified versions, it may be sufficient to use only two haptics 20.
- FIG. 6 A second variant of the fastening of the Fresnel zone structure 13 on the elastically stretchable membrane 14 in such a way that the accommodation activity leads to an expansion of the Fresnel zone structure 13 is shown in FIG. 6 and in an enlarged detail in FIG. 7.
- the membrane 14 is preferably attached to the front or, alternatively, the back of the capsule bag 8.
- the membrane is located over the opening (which can no longer be seen as a result) that was created during the capsulorhexis in order to remove the nucleus of the lens.
- the membrane can be fixed to the capsular bag 8 by suitable means.
- Fig. 7 shows this anterior (or posterior) connecting rings which are set through one of the openings 24 and who are anchored to the capsular bag 8, for example sewn. Gluing is also possible.
- the focal length for a given ring structure 15 is dependent on the wavelength. It is therefore preferred in a further development to provide two or, as FIGS. 8 and 9 show, three (alternatively also more) single ring structures 15a, 15b and 15c in the Fresnel zone structure 13, which generate the same focal length for different wavelengths.
- the wavelength increases from the ring structure 15a to 15b and 15c.
- the individual rings 16a, 16b and 16c of the ring structures 15a, 15b and 15c are absorbent and / or reflective in different spectral ranges. This is shown schematically in FIG.
- the rings 16a of the ring structure 15a have the absorption spectrum 28a, the rings 16b of the ring structure 15b the absorption spectrum 28b and the Rings 16c of the ring structure 15c the absorption spectrum 28c.
- the ring structures are each absorbent in an individual spectral range and, in particular, do not absorb in the spectral range in which one of the other ring structures absorbs.
- each ring structure only acts within the spectral range in which it is absorbent, and the geometry of the ring structure is then also designed for this spectral range.
- the ring structures 15a to 15c generate the same focal length in their respective spectral range.
- a Fresnel zone structure which is chromatically corrected is thus obtained.
- the implementation of the intraocular lens 6 is not restricted to amplitude-modulated Fresnel zone structures.
- phase modulating structures come into question, as shown in FIG. 11.
- the ring structure 15 provided on the flexible membrane 14 e.g. produced by embossing
- rings 16 which modulate the phase of the incident radiation and thus cause the radiation to be bundled in a focus 30.
- the focal length fo in the unstretched state does not correspond to the focal length in the expanded state, which is shown in FIG. Rather, the focus 30 shifts in accordance with the area ratio between the stretched and unstretched state (cf. equation 2 above). In this way, an expansion of the membrane 14 with the ring structure 15 can equally be used for accommodation.
- combinations of phase-modulated Fresnel zone plates according to FIG. 11/12 and amplitude-modulated Fresnel zone plates according to FIG. 3 are possible, either as two separate plates or on a single membrane 14.
- the intraocular lens of FIG. 13 also has the advantage that the adjustment range that can be achieved with accommodation is enlarged.
- This Ausry approximately form is therefore not only advantageous in cases where a greater refractive power is desired but it can also be advantageous in applications that do not require a particularly large refractive power for optical correction during cataract surgery, because the necessary refractive power of the Fresnel zone plate is reduced due to the refractive power caused by the curvature 34.
- a larger optically active zone can be used for the Fresnel zone plate, which improves side effects such as diffraction and transmission.
- a comparison with regard to chromatic errors is preferred. It can, for example, be selected to be so small that the chromatic errors that occur are negligible.
- the accommodative intraocular lens 6 can, as shown in FIGS. 14-16, additionally be supplemented by a non-accommodative part, which is provided in the form of an additional lens 36, which is either posterior or anterior to the elastic part (usually the membrane 14) Intraocular lens 6 is located.
- a non-accommodative part which is provided in the form of an additional lens 36, which is either posterior or anterior to the elastic part (usually the membrane 14) Intraocular lens 6 is located.
- FIG 16 shows how the expansion of the membrane 14 of the intraocular lens 6 can be increased by means of a lever system 38 which is supported on the non-accommodating additional lens 36.
- the expansion indicated by the arrow 32 is converted by the haptics 20 with an element 38 acting as a bilateral lever into a comparatively greater expansion 40 of the flexible part of the intraocular lens 6, i.e. the membrane 14. This increases the extent of accommodation that can be achieved by enlarging the capsular bag equator, which is physiologically predetermined with regard to its maximum enlargement.
Landscapes
- Health & Medical Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- Cardiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Prostheses (AREA)
Abstract
Description
Claims
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102019134386.0A DE102019134386A1 (de) | 2019-12-13 | 2019-12-13 | Intraokularlinse |
| PCT/EP2020/085558 WO2021116298A1 (de) | 2019-12-13 | 2020-12-10 | Intraokularlinse und verfahren zum ersetzen einer natürlichen augenlinse |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EP4072469A1 true EP4072469A1 (de) | 2022-10-19 |
Family
ID=74095779
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP20829810.9A Pending EP4072469A1 (de) | 2019-12-13 | 2020-12-10 | Intraokularlinse und verfahren zum ersetzen einer natürlichen augenlinse |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP4072469A1 (de) |
| DE (1) | DE102019134386A1 (de) |
| WO (1) | WO2021116298A1 (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4608329A4 (de) * | 2023-10-23 | 2026-02-18 | California Inst Of Techn | Flüssigkeitsunterbringende intraokularlinse mit aufgehängter zentrallinse |
Family Cites Families (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3991426A (en) | 1975-02-14 | 1976-11-16 | Leonard Flom | Posterior chamber artificial intraocular lens with retaining means and instruments for use therewith |
| DE2725219A1 (de) | 1977-06-03 | 1978-12-14 | Titmus Eurocon Kontaktlinsen K | Intraokulare kuenstliche augenlinse |
| US4166293A (en) | 1977-06-10 | 1979-09-04 | Anis Aziz Y | Intraocular lens implant |
| US4177526A (en) | 1977-07-22 | 1979-12-11 | Kuppinger John C | Securing device for an intraocular lens |
| US4244060A (en) | 1978-12-01 | 1981-01-13 | Hoffer Kenneth J | Intraocular lens |
| US4242761A (en) | 1979-07-25 | 1981-01-06 | Heyer-Schulte Corporation | Intraocular lens with threadably locked retention loops |
| US4268921A (en) | 1979-10-22 | 1981-05-26 | Kelman Charles D | Intraocular lenses |
| DE2945349C2 (de) | 1979-11-09 | 1983-09-01 | Vsesojuznyj naučno-issledovatel'skij institut glaznych boleznej, Moskva | Künstliche Augenlinse |
| DE3130278C2 (de) | 1981-07-31 | 1984-05-03 | Reiner Dr.med. 6000 Frankfurt Täumer | Intraokulare Vorderkammerlinse |
| US5066301A (en) | 1990-10-09 | 1991-11-19 | Wiley Robert G | Variable focus lens |
| FR2688598A1 (fr) | 1992-03-13 | 1993-09-17 | Thomson Csf | Plaque de fresnel a focale variable. |
| US5443506A (en) | 1992-11-18 | 1995-08-22 | Garabet; Antoine L. | Lens with variable optical properties |
| US5728155A (en) | 1996-01-22 | 1998-03-17 | Quantum Solutions, Inc. | Adjustable intraocular lens |
| US20020128710A1 (en) | 1996-03-18 | 2002-09-12 | Eggleston Harry C. | Modular intraocular implant |
| US6007579A (en) | 1998-01-15 | 1999-12-28 | Visioncare Ltd. | Intraocular carrying member with attachment for telescope |
| FR2778093B1 (fr) | 1998-05-04 | 2000-06-16 | Khalil Hanna | Implant intraoculaire |
| FR2784575B1 (fr) | 1998-10-15 | 2000-12-22 | Megaoptic Gmbh | Implant intraoculaire accommodatif |
| US6152958A (en) * | 1998-12-16 | 2000-11-28 | Nordan; Lee T. | Foldable thin intraocular membrane |
| US20030220687A1 (en) * | 1998-12-16 | 2003-11-27 | Nordan Lee T. | Intraocular thin lens for anterior chamber installation |
| US20030158560A1 (en) | 1999-03-22 | 2003-08-21 | Valdemar Portney | Corrective intraocular lens system, intraocular lenses, and lens handling and installation devices for use therewith, and installation method |
| DE10105080B4 (de) | 2001-02-05 | 2007-01-18 | Marianne Jahn | Verstellbare intraokulare Linse und zugehörige Verstellvorrichtung |
| US6576012B2 (en) | 2001-03-28 | 2003-06-10 | Advanced Medical Optics, Inc. | Binocular lens systems |
| US7118597B2 (en) * | 2001-06-22 | 2006-10-10 | David Miller | Accommodating intraocular lens |
| DE10134072B4 (de) | 2001-07-13 | 2004-03-18 | Geniovis Gmbh | Intraokularlinse |
| DE102004017283A1 (de) | 2004-04-07 | 2005-11-03 | Carl Zeiss | Künstliche Linse für ein Auge |
| JP4480766B2 (ja) | 2004-10-13 | 2010-06-16 | ニューレンズ・リミテッド | 調節式眼内レンズ(aiol)及びそれを含んでいるaiolアッセンブリ |
| US20070010881A1 (en) | 2005-07-11 | 2007-01-11 | Alcon, Inc. | Intraocular lens system |
| CA2673388C (en) | 2006-12-22 | 2015-11-24 | Amo Groningen B.V. | Accommodating intraocular lens, lens system and frame therefor |
| US8066768B2 (en) | 2007-01-29 | 2011-11-29 | Werblin Research & Development Corp. | Intraocular lens system |
| US9398949B2 (en) | 2007-01-29 | 2016-07-26 | Emmetropia, Inc. | Intraocular lens system |
| WO2010093548A1 (en) | 2009-02-10 | 2010-08-19 | Alcon, Inc. | Accommodative intraocular lens system |
| US9492272B2 (en) * | 2009-08-13 | 2016-11-15 | Acufocus, Inc. | Masked intraocular implants and lenses |
| WO2013082545A1 (en) * | 2011-12-02 | 2013-06-06 | Acufocus, Inc. | Ocular mask having selective spectral transmission |
| US9364319B2 (en) * | 2012-09-25 | 2016-06-14 | Valdemar Portney | Refractive-diffractive switchable optical element |
| EP2806828B1 (de) | 2012-01-24 | 2021-07-21 | The Regents of The University of Colorado, A Body Corporate | Entwürfe und verfahren für modulare intraokularlinsen |
| CN104849792A (zh) | 2015-06-01 | 2015-08-19 | 南开大学 | 一种基于改进型分形波带片的老视矫正器件 |
| CN108348327B (zh) | 2015-11-04 | 2021-10-01 | 克拉维斯塔医疗有限公司 | 模块化人工晶状体设计、工具和方法 |
| CN113180886A (zh) | 2015-12-01 | 2021-07-30 | 雷恩斯根公司 | 调节性人工晶状体装置 |
-
2019
- 2019-12-13 DE DE102019134386.0A patent/DE102019134386A1/de active Pending
-
2020
- 2020-12-10 EP EP20829810.9A patent/EP4072469A1/de active Pending
- 2020-12-10 WO PCT/EP2020/085558 patent/WO2021116298A1/de not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| DE102019134386A1 (de) | 2021-06-17 |
| WO2021116298A1 (de) | 2021-06-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2887908B1 (de) | Intraokularlinse, insbesondere kapselsackintraokularlinse | |
| DE60307521T2 (de) | Akkommodative intraokularlinse | |
| DE60307816T2 (de) | Akkommodative intraokularlinse | |
| DE3303803C2 (de) | ||
| DE69526962T2 (de) | Akkomodierendes kuenstliches linsenimplantat | |
| DE602004011072T2 (de) | Intraokularlinsen-system | |
| EP3220859B1 (de) | Brechbare maske zur behandlung von presbyopie | |
| DE68902614T2 (de) | Akkommodierende intraokulare linse. | |
| DE60038372T2 (de) | Intraokularlinsenkombinationen | |
| DE69637497T2 (de) | Anpassbare intraokulare Linse mit T-förmigen Haltebügeln | |
| AU2010300664B2 (en) | Methods for enhancing accommodation of a natural lens of an eye | |
| DE69433855T3 (de) | Intraokularlinse zur Akkommodation | |
| EP1726272B1 (de) | Intraokularlinse | |
| DE112009001492T5 (de) | Akkommodierende intraokulare Linse | |
| DE202013009162U1 (de) | Intraokularlinsen-Baugruppe | |
| EP1457170B1 (de) | Hinterkammerlinse | |
| EP4072469A1 (de) | Intraokularlinse und verfahren zum ersetzen einer natürlichen augenlinse | |
| DE102011053670A1 (de) | Intraokularlinse | |
| DE19637693A1 (de) | Verformbare künstliche intraokulare Augenlinse | |
| EP1863411B1 (de) | Intraokularlinse | |
| US20150134059A1 (en) | Deformable accommodative intraocular lens | |
| EP4408345B1 (de) | Akkommodative intraokularlinse zum erzeugen einer rückstellkraft | |
| EP2535019B1 (de) | Akkommodative intraokulare phake kunstlinse mit hochbrechendem medium | |
| DE112020006407T5 (de) | Intraokulare sekundärlinse und verfahren zu ihrer applikation, die auf die intraokulare linse bei pseudophaken augen aufgeklebt werden kann | |
| DE102010017240B4 (de) | Implantatanordnung zum Implantieren in ein menschliches Auge |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: UNKNOWN |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
| 17P | Request for examination filed |
Effective date: 20220602 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
| DAV | Request for validation of the european patent (deleted) | ||
| DAX | Request for extension of the european patent (deleted) | ||
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
| 17Q | First examination report despatched |
Effective date: 20241115 |